Carmell Therapeutics Corporation
Carmell Therapeutics Corporation (CTCXW) Stock Overview
Explore Carmell Therapeutics Corporation’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
558.2K
P/E Ratio
-0.06
EPS (TTM)
N/A
ROE
2.47%
CTCXW Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Carmell Therapeutics Corporation (CTCXW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.02.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.06 and a market capitalization of 558.2K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.